|
1
|
Sauer R, Becker H, Hohenberger W, Rödel C,
Wittekind C, Fietkau R, Martus P, Tschmelitsch J, Hager E, Hess CF,
et al: Preoperative versus postoperative chemoradiotherapy for
rectal cancer. N Engl J Med. 351:1731–1740. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Lee JW, Lee JH, Kim JG, Oh ST, Chung HJ,
Lee MA, Chun HG, Jeong SM, Yoon SC and Jang HS: Comparison between
preoperative and postoperative concurrent chemoradiotherapy for
rectal cancer: An institutional analysis. Radiat Oncol J.
31:155–161. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Habr-Gama A, Gama-Rodrigues J and Perez
RO: Is tailoring treatment of rectal cancer the only true benefit
of long-course neoadjuvant chemoradiation? Dis Colon Rectum.
56:264–266. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Fleming FJ and Monson JR: The contemporary
(over)treatment of rectal cancer: The goldilocks effect. Dis Colon
Rectum. 57:403–406. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Yeo SG, Kim DY, Kim TH, Chang HJ, Oh JH,
Park W, Choi DH, Nam H, Kim JS, Cho MJ, et al: Pathologic complete
response of primary tumor following preoperative chemoradiotherapy
for locally advanced rectal cancer: Long-term outcomes and
prognostic significance of pathologic nodal status (KROG 09–01).
Ann Surg. 252:998–1004. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Yeo SG, Kim DY and Oh JH: Long-term
survival without surgery following a complete response to
pre-operative chemoradiotherapy for rectal cancer: A case series.
Oncol Lett. 6:1573–1576. 2013.PubMed/NCBI
|
|
7
|
Edge SB, Byrd DR, Compton CC, Fritz AG,
Greene FL and Trotti A: AJCC Cancer Staging Manual (7th). New York:
Springer. 2010.
|
|
8
|
Compton C, Fenoglio-Preiser CM, Pettigrew
N and Fielding LP: American Joint Committee on Cancer prognostic
factors consensus conference: Colorectal Working Group. Cancer.
88:1739–1757. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Park YA, Sohn SK, Seong J, Baik SH, Lee
KY, Kim NK and Cho CW: Serum CEA as a predictor for the response to
preoperative chemoradiation in rectal cancer. J Surg Oncol.
93:145–150. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wallin U, Rothenberger D, Lowry A, Luepker
R and Mellgren A: CEA - a predictor for pathologic complete
response after neoadjuvant therapy for rectal cancer. Dis Colon
Rectum. 56:859–868. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Restivo A, Zorcolo L, Cocco IM, Manunza R,
Margiani C, Marongiu L and Casula G: Elevated CEA levels and low
distance of the tumor from the anal verge are predictors of
incomplete response to chemoradiation in patients with rectal
cancer. Ann Surg Oncol. 20:864–871. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Yoon SM, Kim DY, Kim TH, Jung KH, Chang
HJ, Koom WS, Lim SB, Choi HS, Jeong SY and Park JG: Clinical
parameters predicting pathologic tumor response after preoperative
chemoradiotherapy for rectal cancer. Int J Radiat Oncol Biol Phys.
69:1167–1172. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Sautter-Bihl ML, Hohenberger W, Fietkau R,
Rödel C, Schmidberger H and Sauer R: Rectal cancer: When is the
local recurrence risk low enough to refrain from the aim to prevent
it? Strahlenther Onkol. 189:105–110. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zoccali M and Fichera A: Role of radiation
in intermediate-risk rectal cancer. Ann Surg Oncol. 19:126–130.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Taylor FG, Quirke P, Heald RJ, Moran B,
Blomqvist L, Swift I, Sebag-Montefiore DJ, Tekkis P and Brown G:
MERCURY study group: Preoperative high-resolution magnetic
resonance imaging can identify good prognosis stage I, II, and III
rectal cancer best managed by surgery alone: A prospective,
multicenter, European study. Ann Surg. 253:711–719. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Frasson M, Garcia-Granero E, Roda D,
Flor-Lorente B, Roselló S, Esclapez P, Faus C, Navarro S, Campos S
and Cervantes A: Preoperative chemoradiation may not always be
needed for patients with T3 and T2N+ rectal cancer. Cancer.
117:3118–3125. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Hawkes EA, Cunningham D, Tait D, Brown G
and Chau I: Neoadjuvant chemotherapy alone for early-stage rectal
cancer: An evolving paradigm? Semin Radiat Oncol. 21:196–202. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Yeo SG, Kim DY, Park JW, Choi HS, Oh JH,
Kim SY, Chang HJ, Kim TH and Sohn DK: Stage-to-stage comparison of
preoperative and postoperative chemoradiotherapy for T3 mid or
distal rectal cancer. Int J Radiat Oncol Biol Phys. 82:856–862.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Sauer R, Liersch T, Merkel S, Fietkau R,
Hohenberger W, Hess C, Becker H, Raab HR, Villanueva MT, Witzigmann
H, et al: Preoperative versus postoperative chemoradiotherapy for
locally advanced rectal cancer: Results of the German
CAO/ARO/AIO-94 randomized phase III trial after a median follow-up
of 11 years. J Clin Oncol. 30:1926–1933. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Lee NK, Kim DY, Kim SY, Oh JH, Park W,
Choi DH, Nam TK and Lee KJ: Clinical outcomes of local excision
following preoperative chemoradiotherapy for locally advanced
rectal cancer. Cancer Res Treat. 46:158–164. 2014. View Article : Google Scholar : PubMed/NCBI
|
